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Abstract
Menthol is a widely-used cooling and flavoring agent derived from mint leaves. In the peripheral nervous system, menthol
regulates sensory transduction by activating TRPM8 channels residing specifically in primary sensory neurons. Although
behavioral studies have implicated menthol actions in the brain, no direct central target of menthol has been identified.
Here we show that menthol reduces the excitation of rat hippocampal neurons in culture and suppresses the epileptic
activity induced by pentylenetetrazole injection and electrical kindling in vivo. We found menthol not only enhanced the
currents induced by low concentrations of GABA but also directly activated GABAA receptor (GABAAR) in hippocampal
neurons in culture. Furthermore, in the CA1 region of rat hippocampal slices, menthol enhanced tonic GABAergic inhibition
although phasic GABAergic inhibition was unaffected. Finally, the structure-effect relationship of menthol indicated that
hydroxyl plays a critical role in menthol enhancement of tonic GABAAR. Our results thus reveal a novel cellular mechanism
that may underlie the ambivalent perception and psychophysical effects of menthol and underscore the importance of
tonic inhibition by GABAARs in regulating neuronal activity.
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Introduction
Gamma-aminobutyric acid (GABA) is the major inhibitory
neurotransmitter in the mammalian brain. Its principal action is to
activate ionotropic A-type GABA receptors (GABAARs), leading
to an inward flow of Cl
2 and a hyperpolarizing postsynaptic
response. The GABAergic transmission shapes neural activity via
two spatially and temporally unique modes of inhibition [1]. The
phasic (or synaptic) inhibition results from high-level GABA
transients associated with evoked release of GABA, which activates
synaptic GABAARs, whereas the tonic inhibition is caused
primarily by ambient extracellular GABA acting on extrasynaptic
high-affinity GABAARs [2,3]. Previous studies in brain slices [2,4]
and neuronal cultures [5,6], and in vivo [7] have shown that
different GABAAR subtypes are responsible for mediating tonic
inhibition, depending on brain regions and cell types [1,8]. Recent
studies suggest that tonic inhibition may regulate neural network
excitability [2] and information processing [7]. Impairment of
tonic inhibition may also contribute to pathological states such as
chronic epilepsy [9]. Therefore, the enhancement of GABAergic
tonic inhibition is a promising therapeutic approach for diseases
involving network hyper-excitability.
(2)-Menthol is the best-known monoterpene extracted from the
essential oil of the genus Mentha of the Lamiaceae family. Because
of its pleasant flavor and aroma, and its cooling-anesthetic effect,
menthol is used in many confectionary goods, pharmaceuticals,
oral health care products, cosmetics, tea and tobacco products
[10]. Menthol is also a primary activator of the cold- and menthol-
sensitive TRPM8 channels [11,12]. It facilitates glutamate release
from sensory neurons by increasing intracellular Ca
2+ level via
activation of TRPM8 [13,14], leading to modulation of peripheral
nociception [15,16]. Although behavioral studies have implicated
menthol actions in the central nervous system (CNS) [17], no
direct central target of menthol has been identified. In this study,
we demonstrated the central actions of menthol on hippocampal
neurons and showed a specific function of menthol in suppressing
the excitation of hippocampal neurons by enhancing tonic GABA
inhibition.
Results
Menthol suppresses neuronal excitation in hippocampal
cultures
To explore the effect of menthol in central neurons, we first
examined the menthol’s effect on neuronal firing properties, using
cell-attached voltage-clamp recording [18,19] from cultured
hippocampal neurons. Cultured neurons 12–16 day in vitro (DIV)
had established functional synaptic connections and exhibited
spontaneous spiking in the standard recording solution, with a
mean firing rate of 1.660.4 Hz. This spontaneous spiking is
synaptically driven, since it was completely abolished by bath
addition of 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 3 mM),
a specific antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxa-
zolepropionic acid (AMPA) subtype of glutamate receptors
(Fig. 1A). Application of menthol dose-dependently reduced the
firing rate, with an IC50 of about 5465 mM (Fig. 1D). The
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by the rightward shift in the distribution of interspike intervals
(Fig. 1C). Reducing the extracellular concentration of Mg
2+
induces hyper-excitation in both hippocampal slices [20] and cell
cultures [21] by enhancing glutamatergic transmission through
elevated evoked glutamate release and increased activity of N-
methyl-D-aspartate (NMDA) subtype of glutamate receptors. We
found that the firing rate was significantly increased following the
perfusion with the Mg
2+-free solution (Fig. 1B and 1C), and
menthol application dose-dependently reduced the firing rate with
an IC50 (6466 mM) similar to that found above for the suppression
effect in standard recording solution (Fig. 1D). Thus menthol
suppresses both spontaneous spiking and hyperactivity in hippo-
campal cultures.
Synergistic activation of GABAARs by menthol and GABA
The suppression of neuronal excitation by menthol was not due
to its effect on intrinsic membrane excitability of neurons. In the
presence of a cocktail of transmitter receptor antagonists, including
CNQX (10 mM), D-AP5 (20 mM, for NMDA receptors), bicucul-
line (BMI, 10 mM, for GABAARs) and strychnine (STR, 1 mM, for
glycine receptors), we found that the firing frequencies of cultured
hippocampal neurons induced by the same set of step-depolariza-
tion currents were identical before and after addition of menthol
(300 mM, Fig. S1). Although TRPM8 protein is present in sensory
neurons [11], we detected no TRPM8 mRNA in either cultured
hippocampal neurons or rat hippocampus tissue of rats (Fig. S2),
consistent with the idea that menthol regulates neuronal function
via a mechanism independent of TRPM8. Based on the finding
that menthol potentiates the response of recombinant GABAARs
expressed in Xenopus oocytes [22], we examined the effect of
menthol on the activation of GABAARs in hippocampal neurons.
Menthol by itself had no effect on the resting membrane current
(Fig. 2A and 2B) at low concentrations (#100 mM), but it dose-
dependently induced inward currents (IMent) at higher concentra-
tions (EC50=490 mM, Fig. 3). However, at 100 mM, menthol
produced a marked enhancement of GABA-evoked current when
co-applied with GABA (1 mM, Fig. 2B). The enhancement was
quantified by measuring the peak amplitude of the membrane
current evoked by a 20-s pulse of GABA alone (IGABA) and after
co-application of GABA and menthol of different concentrations
(IGABA+Ment) in the same cell (Fig. 2B and 2C). The results indicate
that the threshold concentration of menthol for enhancing IGABA
was between 10–30 mM. The finding that the magnitude of
IGABA+Ment at high menthol concentrations (0.3 and 1 mM) was
larger than the arithmetic sum of IGABA and IMent is also consistent
with a menthol-induced enhancement of IGABA. Importantly, IMent
was virtually abolished by BMI (10 mM) and picrotoxin (PTX,
100 mM), but not by STR (1 mM) (Fig. 3), similar to that found for
IGABA or IGABA+Ment (data not shown). Furthermore, the reversal
potential for IGABA+Ment was not significantly different from that
found for IGABA (data not shown), and that of IMent depended on
internal Cl
2 concentration in the same manner as that of IGABA
(Fig. 3). Together, these results suggest that menthol reduce
Figure 1. The inhibitory effect of menthol on synaptically driven spiking in hippocampal cultures. (A) Typical traces of spontaneous
spiking from one cell in the presence or absence of menthol. (B) Typical traces of zero Mg
2+-induced spiking from the same cell in the presence or
absence of menthol. (C) The distribution of interspike interval obtained from A and B showing the effect of menthol on spontaneous spiking and
elevated spiking. (D) Concentration-dependent inhibition of menthol on spontaneous and zero Mg
2+-induced firing rate. (n=6).
doi:10.1371/journal.pone.0003386.g001
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inhibition.
The ambient GABA in the cerebral spinal fluid is estimated to
be 0.8–2.9 mM [23], a concentration that may produce tonic
neuronal inhibition by activating slowly-desensitizing extrasynap-
tic high-affinity GABAARs [24]. However, the GABA concentra-
tion in the synaptic cleft can reach millimolar levels during
GABAergic transmission [25]. When the effect of menthol on
GABA-induced currents in cultured hippocampal neurons was
measured over a wide range (1–1000 mM) of GABA concentra-
tions, we found that the enhancing effect on the peak current
amplitude occurred only when GABA concentration was #3 mM
(Fig. 2D and 2E), suggesting that menthol preferentially acts on
extrasynaptic high-affinity GABAARs.
The enhancement of menthol on tonic GABA currents in
CA1 neuron of rat hippocampus
The above findings that menthol preferentially potentiated
GABAAR-mediated currents at low GABA concentrations
prompted us to examine the GABAAR-mediated tonic currents
in hippocampal slices. Under the condition of high Cl
2
concentration (147 mM) in the whole-cell recording pipette, the
basal membrane current of CA1 pyramidal neurons underwent an
upward shift following bath application of BMI, revealing the tonic
Figure 2. Synergistic activation of GABAARs by menthol and GABA. (A) Typical traces showing the currents evoked by 1 mM GABA, 100 mM
menthol, 1 mM menthol, 1 mM GABA plus 100 mM menthol and 1 mM GABA plus 1 mM menthol. (B) Histograms showing relative IGABA, Iment,
IGABA+ment.( C) The concentration-response relationship of synergic action of menthol with 1 mM GABA. (D) Typical traces showing the current evoked
by different concentrations of GABA in the absence or presence of 100 mM menthol. (E) Statistic data showing the relative currents induced by
100 mM menthol plus various concentrations of GABA. * P,0.05 and *** P,0.001, compared with IGABA in the absence of menthol.
doi:10.1371/journal.pone.0003386.g002
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menthol (300 mM) induced the downward shift of the membrane
current, which was eliminated by subsequent application of BMI.
This is consistent with notion that menthol had potentiated the
action of endogenous tonic GABA. Interestingly, we found that
menthol at the same concentration had no effect on the peak
amplitude, rise time, decay time and frequency of spontaneous
inhibitory postsynaptic currents (mIPSCs) (Fig. 4C–F). This is in
line with the above finding in cultured hippocampal neurons that
menthol selectively enhances tonic rather than synaptic (phasic)
inhibition of GABA.
Further support of a specific action of menthol on GABAergic
inhibition came from the analysis of spontaneous miniature
excitatory post-synaptic currents (mEPSCs). In cultured hippo-
campal neurons, neither glutamate-activated macroscopic currents
nor the amplitude and frequency of mEPSCs were affected by
menthol (Fig. S3). These results further suggest that menthol
reduced hippocampal neuronal excitation through a specific
Figure 3. Pharmacological and electrophysiological properties of menthol-activated currents (Iment) in cultured hippocampal
neurons. (A) Typical traces showing the currents induced by various concentration of menthol. (B) Concentration-response relationship of Iment in
cultured hippocampal neurons. All peak currents are normalized to the peak amplitude evoked by 1 mM menthol (*). Symbols represent the average
response for 6–13 neurons. (C) Typical traces of Iment evoked by 1 mM menthol in the absence or presence of 10 mM BMI (n=15), 100 mM PTX (n=5)
and 1 mM STR (n=15). (D) Summary results from all experiments similar to that shown in C showing the relative Iment in the presence of BMI, PTX and
STR. Dashed line indicates the control values without antagonist treatment. (E) Typical traces showing Iment evoked by 1 mM menthol at various
holding potentials (VH) with [Cl
2]i of 153 mM (upper traces) and 33 mM (lower traces). (F) The current-voltage relationships of Iment in the condition
of [Cl
2]i of 153 mM and 33 mM, respectively. The reversal potential of Iment moved toward hyperpolarizing direction by lowering [Cl
2]i.( G) Summary
results showing the reversal potentials for Iment in 153 mM [Cl
2]i and 33 mM [Cl
2]i, respectively.
doi:10.1371/journal.pone.0003386.g003
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that menthol mimics GABA by directly activating GABAARs at
the high concentration range of 0.3 to 3 mM in cultured
hippocampal neurons (Fig. 3), our data suggest that menthol
could activate and sensitize GABAARs and thereby regulate
hippocampal neuronal excitation.
Figure 4. Selective enhancement of GABAAR-mediated tonic currents by menthol. (A) Voltage-clamp recordings from CA1 pyramidal
neurons showing GABAergic tonic currents in the absence and presence of 300 mM menthol. The tonic current plotted at 500-ms intervals was
revealed by 30 mM BMI. (B) Summary data showing the change of tonic currents by 300 mM menthol (n=6, **P,0.01, compared with the control
group without menthol treatment, paired t-test). (C) Representative traces showing GABAergic mIPSCs in the absence or presence of 300 mM
menthol. Averaged mIPSCs in the absence or presence of 300 mM menthol are shown in the pane (D) Summary data showing normalized amplitude,
frequency and kinetics of GABAergic mIPSCs in the presence of menthol (n=14). Dashed line indicates the control values without menthol treatment.
(E) Normalized cumulative curves showing the effect of menthol on the amplitude of GABAergic mIPSCs from the sample neuron. (F) Normalized
cumulative curves showing the effect of menthol on the frequency of GABAergic mIPSCs from the sample neuron.
doi:10.1371/journal.pone.0003386.g004
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excitability
Network hyperactivity of the brain is the cause of epileptic
seizures. Many antiepileptic agents exert anticonvulsant effect
through inhibiting hyperactivity. We have used pentylenetetrazole
(PTZ) model of epilepsy, a widely accepted method for evaluation
of anticonvulsant drug, to examine whether menthol also inhibits
in vivo hyperactivity. The target of PTZ is known to include
GABAARs [26]. As shown in Fig. 5, clonic and tonic seizures were
observed in mice within 30 min after PTZ injection. Administra-
tion of menthol (200 mg/kg, i.p.) significantly prolonged the
latency to clonic (p,0.01 compared with Ctrl, Fig. 5A) and tonic
seizures (p,0.05 compared with Ctrl, Fig. 5A). In addition,
menthol markedly reduced the mortality of the mice (Fig. 5B).
Therefore, menthol has an anticonvulsant effect in the PTZ mouse
model, presumably through its potentiation on tonic GABAergic
inhibition.
To further ascertain whether menthol inhibits hippocampal
hyperactivity in situ, we investigated the effect of intracerebroven-
tricular injection of menthol on hippocampal kindling, a more
stable rat model of epilepsy. In these experiments, the anticon-
vulsive drug phenobarbital (PB) was used as a positive control. In
normal rats prior to kindling, the afterdischarge threshold for rats
injected with either menthol (780 mgi n5mL) or PB (640 mgi n
5 mL) was significantly higher than that observed in vehicle-
injected rats (p,0.01 compared with Ctrl, Fig. 5D). For fully
kindled rats (5 constitutive 5 class seizures by Racine’s standard
classification), we found that menthol or PB treatment significantly
reduced the susceptibility of rats to seizure (p,0.01 compared with
Ctrl, Fig. 5E) and the afterdischarge duration (Fig. 5C and 5F), as
compared to those found in the vehicle-injected rats (Ctrl).
Therefore, menthol exerts anticonvulsant effect in both PTZ and
kindling models, consistent with the enhanced tonic GABAergic
inhibition, which plays an important role in regulating network
hyperactivity.
The critical role of hydroxyl group in menthol
enhancement of GABAARs
Finally, in order to further examine the structural basis of
menthol modulation on GABAARs, we explored the structure-
activity relationship of menthol enhancement on GABAARs.
There are four main isomers of menthol: (2)-menthol, (+)-
menthol, (6)-menthol and (2)-neomenthol (Fig. 6A). The menthol
isomers all significantly enhanced IGABA induced by 1 mM GABA
in cultured hippocampal neurons (Fig. 6B). In addition, we tested
another three structurally related chemicals of menthol, (2)-
isopulegol, JE207 and (2)-menthyl chloride, on IGABA induced by
1 mM GABA. As shown in Fig. 6B, (2)-isopulegol significantly
enhanced IGABA, while JE207 and (2)-menthyl chloride, the
hydroxyl substitutes of menthol, have no significant effect on
IGABA. Therefore, these results indicate that the hydroxyl plays a
critical role in menthol enhancement of GABAARs.
Discussion
In cultured hippocampal neurons, we found that the enhancing
effect of menthol occurred only when GABA concentration was
#3 mM, suggesting that menthol preferentially acts on extra-
synaptic high-affinity GABAARs. In accordance with the modu-
lation of menthol on GABA responses in cultured neurons, we
observed a differential effect of menthol on tonic GABA currents
and GABAergic mIPSCs in CA1 pyramidal neurons of hippo-
campal slices. Notably, the tonic current activated by ambient low
concentration of GABA was significantly enhanced by menthol,
while the phasic GABAergic current mIPSC was not affected.
Therefore, these results indicate that menthol selectively enhances
tonic GABAergic inhibition in CA1 pyramidal neurons of the
hippocampus.
The ambient GABA concentration in the extracellular space is
estimated to be 0.8–2.9 mM [23], which is sufficient to activate a
small percentage of high-affinity GABAARs. Our data show that
menthol significantly suppressed spontaneous activity of cultured
hippocampal neurons. Furthermore, hippocampal neurons in culture
are capable of forming extensive synaptic networks that display
physiological functions such as synaptic currents and zero Mg
2+-
induced epileptiform activity [21,27]. Not surprisingly, the hyper-
excitability of neurons perfused with Mg
2+-free medium was also
inhibited by the menthol treatment. In agreement with other studies
on the activation of tonic GABAergic receptors by ambient GABA in
cultured hippocampal neurons [6,28], our results suggest that
menthol suppresses the neuronal excitability mainly via enhancing
GABAAR-mediated tonic inhibition in the hippocampus.
A recent study suggests that extrasynaptic GABAARs were
optimally activated by ambient GABA under physiological
conditions and a further increase in extracellular GABA
concentration would not significantly enhance the effect of tonic
inhibition on neuronal excitability [29]. Therefore, the functional
potentiation of tonically activated GABAARs might be a promising
therapeutic approach to treating diseases involving hyper-excit-
ability such as epileptic seizures. Different animal models that
reflect certain kinds of epilepsy are used to evaluate the effect of
anticonvulsant drugs. Among which, PTZ has been reported to
produce seizures by inhibiting GABAergic neurotransmission [30].
In the present study, therefore, PTZ seizure model was firstly used
to examine the in vivo actions of menthol, which acts selectively at
GABAAR-mediated tonic inhibition. Our results demonstrated
that systematical administration of menthol exerts anticonvulsant
effects by prolonging the latency of clonic and tonic seizures
induced by PTZ. A previous study also showed that intraperito-
neal administration of menthol caused ambulation-promoting
effect in mice, suggesting that menthol could enter the brain and
reach an effective concentration [17]. Given the capability of
menthol to penetrate blood-brain barrier, as suggested by the
previous [17] and the present data (Fig. 5A and 5B), it is likely that
menthol intake may be potentially beneficial for lowering network
hyperactivity under both normal and pathological conditions.
Kindling represents the propagation of the epileptic discharge to
distal sites and the possible recruitment of those sites into the
discharge, leading to enhanced sensitivity to focal electrical
stimulation. Therefore, hippocampal kindling is a widely accepted
model of temporal lobe epilepsy [31,32], which has been validated
as a reliable predictor of anticonvulsant drug efficacy [33]. We
found that menthol increased the afterdischarge threshold,
prolonged the afterdischarge duration, and reduced the seizure
susceptibility of hippocampal kindled rats. These results, together
with the anticonvulsant effect of menthol in PTZ-treated mice,
strongly support a role of menthol-enhancing tonic inhibition in
preventing epileptiform hyper-excitability.
There is mounting evidence for extrasynaptic GABAARs having
subunit compositions different from those of synaptic receptors
[3,34–36]. The tonic GABAergic inhibition is mediated by a6d-
containing GABAARs in cerebellar granule cells [34], but by d-
subunit-containing and a5-subunit-containing GABAARs in
dentate gyrus granule cells [34] and hippocampal pyramidal
neurons [1,35], respectively. Selective modulators of tonically
activated receptor are valuable tools for investigating the function
of tonic inhibition. Previous studies suggest that the a5 subunit is a
specific subunit forming extrasynaptic receptors in hippocampal
Menthol Modulation of GABAAR
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decrease of tonic inhibition in both CA1 and CA3 pyramidal
neurons of adult gabra5
2/2 mouse hippocampal slices was
observed [37]. This selective decrease in tonic inhibition leads to
epileptiform hyper-excitability in the CA3 pyramidal layer. Here,
we demonstrate that menthol is a selective enhancer of tonic
inhibition of hippocampal pyramidal neurons. Therefore, the
suppression of neuronal hyper-excitability and epileptiform
activity through selective enhancement of tonic inhibition in
pyramidal neurons further confirm that tonic inhibition plays an
important role in controlling the network excitability including
both physiological oscillations and the pathological propagation of
Figure 5. Effects of menthol on seizures of PTZ treated mice and hippocampal kindled rats. (A) Effect of menthol on the latency from PTZ
injection to the clonic (**P,0.01 compared with Ctrl, One-Way ANOVA) and tonic (*P,0.05 compared with Ctrl) convulsion. (B) Effect of menthol on
mortality in mice after PTZ injection. (C) Typical traces showing the effect of menthol and PB on the afterdischarge in fully kindled rats. (D) The
afterdischarge (AD) threshold induced by first stimulus in rats treated with vehicle, menthol and PB (**P,0.01 compared with Ctrl, n=10). (E) The
seizure stage in fully kindled rats treated with vehicle, menthol and PB (**P,0.01 compared with Ctrl, n=6). (F) Summary data showing
afterdischarge duration in Ctrl, menthol and PB group (**P,0.01 compared with Ctrl, n=6).
doi:10.1371/journal.pone.0003386.g005
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subtype of activated GABAARs. However, this is not really
relevant in this case as it is the concentration of ambient GABA
that determines which receptors (e.g. tonic versus phasic) are
activated by menthol and not menthol per se.
Finally, it would be of some interest to know something more
about the mechanisms of menthol’s effect on GABAARs. In this
regard, a recent study examined menthol’s actions on GABAARs
compared to sedatives (benzodiazepines) and intravenous anes-
thetics (barbiturates, steroids, etomidate and propofol) [38]. The
study indicates that menthol exerts its actions on GABAARs via
sites distinct from benzodiazepines, steroids and barbiturates, and
via sites important for modulation by propofol. This result is not
unexpected given the apparent structural similarities between
menthol and propofol (e.g. positioning of an isopropyl group
adjacent to their respective hydroxyl groups). Interestingly,
propofol at clinically-relevant concentrations selectively enhances
tonic currents activated by GABA at low concentrations in
Figure 6. Effects of menthol isomers, (2)-isopulegol, JE207 and (2)-menthyl chloride on GABAAR. (A) Chemical structures of menthol
isomers, (2)-isopulegol, JE207 and (2)-menthyl chloride. (B) Summary of data showing the relative currents induced by 1 mM GABA in the presence
of 300 mM various menthol isomers, (2)-isopulegol, JE207 or (2)-menthyl chloride.
doi:10.1371/journal.pone.0003386.g006
Menthol Modulation of GABAAR
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the idea that menthol and propofol may modulate GABAARs with
a similar molecular mechanism.
In conclusion, the present results suggest that menthol
selectively enhances tonic inhibition mediated by high-affinity,
slowly desensitizing GABAARs in CA1 pyramidal neurons of rat
hippocampus, leading to inhibition of in vitro neuronal excitability
and in vivo network hyper-excitability of the hippocampus. Our
results, therefore, reveal a novel role of menthol in the mammalian
CNS and underscore the importance of tonic inhibition in
controlling neuronal excitability.
Materials and Methods
Cell culture and electrophysiological recording
Animals were treated in accordance with the Animal Care and
Use Committee of the Institute of Neuroscience. Primary
hippocampal neurons were cultured as previously described
[39]. Whole-cell or cell-attached recordings were made using a
patch-clamp amplifier (Axon 200B, Axon Instruments, Foster
City, CA, USA). The standard extracellular solution contained
(mM): 150 NaCl, 5 KCl, 1 MgCl2, 2 CaCl2, 10 N-hydroxyethyl-
piperazine-NV-2-ethanesulphonic acid (HEPES), and 10 glucose
(pH 7.3 with Tris-base, 325–330 milliosmolar with sucrose). The
pipette solution with the high Cl
2 concentration was composed of
(mM): 120 KCl, 30 NaCl, 1 MgCl2, 0.5 CaCl2, 5 EGTA, 2 Mg-
ATP, 10 HEPES, pH 7.3 adjusted with Tris-base. When I-V
relationships of the currents were examined, tetrodotoxin (TTX,
300 nM) and CdCl2 (100 mM) were added to the standard
extracellular solution and K
+ was replaced with Cs
+ in the pipette
solution. The pipette solution with the low Cl
2 concentration
contained (mM): 120 CsOH, 30 NaCl, 0.2 EGTA, 2 Mg-ATP, 10
HEPES, pH was adjusted to 7.3 with gluconic acid. Additionally,
action-potential discharges were recorded using whole-cell cur-
rent-clamp method with the K-gluconate pipette solution
containing (mM) 150 K-gluconate, 9 NaCl, 1 MgCl2, 0.2 EGTA,
10 HEPES, pH 7.3 adjusted with Tris-base.
Membrane currents were sampled and analyzed using a
Digidata 1320A interface and a personal computer with Clampex
and Clampfit software (Version 9.0.1, Axon Instruments). Unless
otherwise noted, the membrane potential was held at 250 mV for
all whole-cell current recordings, and the patch potential was held
at 0 mV for recording firing activity under cell-attached voltage-
clamp mode. In cell-attached voltage-clamp recording, firing rate
was evaluated from the mean interspike interval, and analyzed
with the MiniAnalysis 6.0.1 program (Synaptosoft, Decatur, GA).
Concentration-response curves were drawn according to a
modified Michaelis-Menten equation by the method of least-
squares (the Newton-Raphson method) after normalizing the
amplitude of the response: I=Imax C
h/(C
h+EC50
h), where I is the
normalized value of the current, Imax is the maximal response, C is
the drug concentration, EC50 is the concentration which induces
the half-maximal response and h is the apparent Hill coefficient.
Brain slices preparation and electrophysiological
recordings
Sprague-Dawley rats (14–21 days after birth) were anesthetized
with halothane. Brains were quickly removed and 400 mm coronal
hippocampal slices were cut in well-oxygenated ice-cold artificial
cerebrospinal fluid (ACSF) containing 126 mM NaCl, 2.5 mM
KCl, 10 mM D-glucose, 2 mM MgSO4, 2 mM CaCl2, 1.25 mM
NaH2PO4, and 26 mM NaHCO3 (pH 7.3–7.4 when bubbled with
95% O2 and 5% CO2). Immediately after cutting, slices were
incubated at 3661uC for 1 h, followed by room temperature (22–
25uC) incubation in oxygenated ACSF before recording. Whole-
cell patch clamp recordings were made from hippocampal CA1
pyramidal neurons under control by infrared-differential interfer-
ence contrast (IR-DIC) video microscope (Olympus, BX51WI).
The holding potential was 260 mV. Patch pipettes had open tip
resistances of 3–5 MV when filled with an intracellular solution
that contained 140 mM CsCl, 10 mM HEPES, 1 mM MgCl2,
0.1 mM EGTA, 4 mM NaCl, 2 mM Mg-ATP, 0.3 mM Na-GTP,
5 mM lidocaine N-ethylbromide (QX-314) (pH 7.3, 280–290
milliosmolar). The extracellular recording solution contained
3 mM kynurenic acid and 1 mM TTX were used to block
ionotropic glutamate receptors and action potential, respectively.
During the experiments, 5 mM GABA was added to enlarge the
basal tonic currents[40]. To evaluate GABA tonic currents,
30 mM BMI was used. The MiniAnalysis 6.0.1 program
(Synaptosoft, Decatur, GA) was used to analyze mIPSCs.
PTZ seizures test
Male ICR mice (20–25 g) received daily administration of
200 mg/kg menthol (1 ml/kg i.p.) for drug group and saline for
control group for 3 days. Menthol was suspended in 1% Tween
80/distilled water for i.p. injection. Thirty minutes after the last
injection, PTZ was administered at 85 mg/kg, i.p [41]. This dose
produces the following behavioral changes: myoclonus, defined as
a whole-body twitch; clonic seizures, manifested by clonic spasms
often followed by stupor or unusual posturing; and tonic seizures
consisted of tonic hind limb extension, which is usually the lethal
component in approximately 50% of the mice under normal
conditions. The latencies to the first clonic seizure and to the tonic
extension as well as mortality were visually evaluated during
30 min after PTZ administration.
Kindling procedure and anticonvulsant test
Adult male Sprague-Dawley rats weighing 200–250 g were
maintained on a 12 h light/dark cycle with ad libitum access to
food and water. Under chloral hydrate (250 mg/kg; i.p.)
anesthesia, bipolar electrode of stainless steel used for stimulation
and recording was stereotaxically implanted in the right
hippocampal CA1 (4.0 mm posterior to bregma, 2.6 mm lateral
to the midline, 2.5 mm below dura). Four screws were inserted
into the skull through a drilled hole without piercing the dura. One
served as the reference (6.0 mm posterior to bregma, 3.0 mm left
lateral to the midline) in the electroencephalogram (EEG)
recording. Cannula was implanted into the left lateral ventricle
(0.8 mm posterior to bregma, 1.5 mm lateral to the midline, and
4.0 mm below the skull surface) for drug infusion. Cannula,
electrodes and screws were fixed with a mixture of acrylic and
dental cement. After a postoperative recovery period of at least 7
days, the electroencephalographic seizure threshold was deter-
mined by application of a 1 s train of 1 ms monophasic
rectangular pulses at 60 Hz beginning at 50 mA. The 25 mA steps
were administered at 2 min interval until an afterdischarge lasting
at least 5 s was detected. Drugs were administrated by intracer-
ebroventricular injection at 20 min before afterdischarge threshold
test. The intensity of afterdischarge threshold plus 100 mA was
administered twice a day during following days. The behavioral
progression of kindling-induced seizures was scored according to
Racine’s standard classification [32]: 0, no reaction; 1, stereotype
mounting, eye blinking and/or mild facial clonus; 2, head nodding
and/or several facial clonus; 3, myoclonic jerks in the forelimbs; 4,
clonic convulsions in the forelimbs with rearing; and 5, generalized
clonic convulsions associated with loss of balance. Fully kindled
was defined by the seizure occurrence of three consecutive class 5.
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stimulations without drug administration until the animals reached
5 constitutive 5 class seizures. Rats were acutely administered with
vehicle (5 ml DMSO), menthol (780 mgi n5ml DMSO solution)
and PB (640 mgi n5 ml DMSO solution), respectively, by
intracerebroventricular injection 20 min before stimulation to test
the class of seizures.
Drugs
All drugs were purchased from Sigma except that the
compound JE207 was kindly provided by Kunming Institute of
Botany, Chinese Academy of Sciences. For the electrophysiolog-
ical experiments, the tested drugs were initially dissolved as
concentrated stock solutions in DMSO and subsequently diluted
to the desired concentration in perfusion solution.
Statistical analysis
Group data are presented as mean6s.e.m. Statistical compar-
isons were made with Student’s t-test or One-way ANOVA.
P,0.05 was considered statistically significant.
Supporting Information
Figure S1 Lack of effect of menthol on action-potential
discharge. (A) Representative traces showing the sustained
action-potential discharges evoked by injection of various
depolarizing current (30 pA, 110 pA and 190 pA) in cultured
hippocampal neurons in the absence or presence of 300 mM
menthol. Synaptic transmission was blocked by CNQX (10 mM),
D-AP5 (20 mM), BMI (10 mM) and STN (1 mM). (B) The
frequency of action-potential discharge evoked by various current
intensity (30–210 pA, 500 ms) in the absence or presence of
300 mM menthol. n=11–15.
Found at: doi:10.1371/journal.pone.0003386.s001 (1.61 MB TIF)
Figure S2 Lack of TRPM8 expression in cultured hippocampal
neurons and hippocampus tissue. (A) Reverse transcriptase-PCR
primers to probe TRPM8. (B) Agarose gel electrophoresis of
mRNA products obtained after amplification of base pair
sequence specific for TRPM8 with reverse transcriptase-PCR.
Evaluation of the constitutively expressed actin gene was included
as a quality control for the cDNA.
Found at: doi:10.1371/journal.pone.0003386.s002 (2.27 MB TIF)
Figure S3 Lack of menthol effect on currents mediated by
ionotropic glutamate receptors. (A) Representative traces showing
the currents evoked by 100 mM glutamate in the absence or
presence of 300 mM menthol. All experiments were performed in
Mg
2+-free extracellular solution containing 1 mM glycine. (B)
Summary results from all experiments similar to that shown in A,
illustrating the lack of effect of menthol on currents mediated by
ionotropic glutamate receptors. n=5. (C) Representative traces
showing mEPSCs in the absence or presence of 300 mM menthol.
Averaged mEPSCs in the absence or presence of 300 mM menthol
are shown in the pane. Miniature EPSCs were recorded in the
presence of 300 nM TTX plus 10 mM BMI and were completely
blocked by 3 mM D-AP5 and 10 mM CNQX. (D) Normalized
cumulative curves showing the effect of menthol on the amplitude
of mEPSCs from the sample neuron. (E) Normalized cumulative
curves showing the effect of menthol on the frequency of mEPSCs
from the sample neuron. (F) Summary data showing normalized
amplitude, frequency of mEPSCs in the presence of menthol
(n=5). Dashed line indicates the control values without menthol
treatment.
Found at: doi:10.1371/journal.pone.0003386.s003 (9.40 MB TIF)
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